{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:59:14Z","timestamp":1793224754319,"version":"4.5.0"},"reference-count":45,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Essential tremor (ET) is a common neurological disorder, typically presenting as bilateral, rhythmic, and symmetric kinetic or postural tremors. In contrast, Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder, characterized by resting tremor, rigidity, bradykinesia, and postural instability. Although both disorders involve tremor, ET and PD differ in clinical presentation and pathophysiology: ET generally involves action tremor and has a strong familial component, while PD more commonly presents with resting tremor and a weaker family history. A subset of ET patients may develop Parkinsonian features over time, although the relationship between ET and subsequent PD remains unclear. Genetic studies have identified only a few pathogenic variants in ET, suggesting it develops as a result of multifactorial genetic and environmental influences rather than simple Mendelian inheritance. ET is also recognized as a risk factor for developing PD, although the underlying mechanisms remain poorly understood. This study aimed to clarify potential genetic overlaps and distinctions in patients diagnosed with both ET and PD. Materials and Methods: We retrospectively analyzed 40 patients with a family history of ET or PD who were initially diagnosed with ET and later developed PD. Genetic screening and clinical assessments were conducted to investigate associated variants and clinical features. Results: Among these 40 patients, 17 different mutations were detected in 16 individuals. Three pathogenic or likely pathogenic variants were identified. The clinical characteristics and treatment responses of these patients were reviewed in relation to their genetic findings. Notably, none of the identified variants had previously been reported in association with PD following ET. Conclusions: A comprehensive clinical and genetic evaluation of ET patients who develop PD may offer insights into the underlying pathophysiology and inform future therapeutic strategies. Our findings support the need for further studies to explore the genetic landscape of patients with overlapping ET and PD features.<\/jats:p>","DOI":"10.3390\/medicina61071184","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T03:54:28Z","timestamp":1751255668000},"page":"1184","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical and Genetic Characteristics of Patients with Essential Tremor Who Develop Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-9249","authenticated-orcid":false,"given":"Gulseren","family":"Buyukserbetci","sequence":"first","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Balikesir University, 10145 Balikesir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilmi","family":"Bolat","sequence":"additional","affiliation":[{"name":"Medical Genetics Department, Faculty of Medicine, Balikesir University, 10145 Balikesir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ummu Serpil","family":"Sari","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Balikesir University, 10145 Balikesir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Turan","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Balikesir University, 10145 Balikesir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayla Solmaz","family":"Avcikurt","sequence":"additional","affiliation":[{"name":"Department of Medical Biology, Faculty of Medicine, Balikesir University, 10145 Balikesir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7129-948X","authenticated-orcid":false,"given":"Figen","family":"Esmeli","sequence":"additional","affiliation":[{"name":"Neurology Department, Faculty of Medicine, Balikesir University, 10145 Balikesir, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jamaneurol.2021.4781","article-title":"Association of essential tremor with novel risk loci: A genome-wide association study and meta-analysis","volume":"79","author":"Liao","year":"2022","journal-title":"JAMA Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"18285","DOI":"10.1073\/pnas.1419581111","article-title":"Mitochondrial serine protease HTRA2 p.G399S in a kindred with essential tremor and Parkinson disease","volume":"111","author":"Gulsuner","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/ejhg.2014.164","article-title":"VPS35 and DNAJC13 disease-causing variants in essential tremor","volume":"23","author":"Ross","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/mds.28031","article-title":"Multiomics analyses identify genes and pathways relevant to essential tremor","volume":"35","author":"Liao","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_5","first-page":"S176","article-title":"Genetics of essential tremor","volume":"22","author":"Tio","year":"2016","journal-title":"Disorders"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1016\/j.parkreldis.2015.08.034","article-title":"Nonmotor symptoms in essential tremor: A review of the current data and state of the field","volume":"22","author":"Louis","year":"2015","journal-title":"Park. Relat. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Skuladottir, A.T., Stefansdottir, L., Halldorsson, G.H., Stefansson, O.A., Bjornsdottir, A., Jonsson, P., Palmadottir, V., Thorgeirsson, T.E., Walters, G.B., and Gisladottir, R.S. (2024). GWAS meta-analysis reveals key risk loci in essential tremor pathogenesis. Commun. Biol., 7.","DOI":"10.1038\/s42003-024-06207-4"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"119.e7","DOI":"10.1016\/j.neurobiolaging.2020.10.019","article-title":"Association study of DNAJC13, UCHL1, HTRA2, GIGYF2 and EIF4G1 with Parkinson\u2019s disease","volume":"100","author":"Saini","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41531-023-00577-y","article-title":"Exploring the link between essential tremor and Parkinson\u2019s disease","volume":"9","author":"Yoo","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Louis, E.D. (2025). The Association Between Essential Tremor and Parkinson\u2019s Disease: A Systematic Review of Clinical and Epidemiological Studies. J. Clin. Med., 14.","DOI":"10.3390\/jcm14082637"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870131303","article-title":"Consensus statement of the Movement Disorder Society on tremor","volume":"13","author":"Deuschl","year":"1998","journal-title":"Mov. Disord."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mdc3.12560","article-title":"Comparison of the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor Rating Assessment Scale","volume":"5","author":"Ondo","year":"2017","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society UPDRS Revision Task Force. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: Onset, progression, mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","article-title":"Fast and accurate long-read alignment with Burrows\u2013Wheeler transform","volume":"26","author":"Li","year":"2010","journal-title":"Bioinformatics"},{"key":"ref_16","first-page":"11.10.1","article-title":"From FastQ data to high confidence variant calls: The Genome Analysis Toolkit best practices pipeline","volume":"11","author":"Carneiro","year":"2013","journal-title":"Curr. Protoc. Bioinform."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"McLaren, W., Gil, L., Hunt, S.E., Riat, H.S., Ritchie, G.R.S., Thormann, A., Flicek, P., and Cunningham, F. (2016). The Ensembl Variant Effect Predictor. Genome Biol., 17.","DOI":"10.1186\/s13059-016-0974-4"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Candel-Parra, E., C\u00f3rcoles-Jim\u00e9nez, M.P., Delicado-Useros, V., Hern\u00e1ndez-Mart\u00ednez, A., and Molina-Alarc\u00f3n, M. (2021). Evolution of Quality of Life in Persons with Parkinson\u2019s Disease: A Prospective Cohort Study. J. Clin. Med., 10.","DOI":"10.3390\/jcm10091824"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.26719\/emhj.23.013","article-title":"Systematic review and meta-analysis of the quality-of-life of patients with Parkinson\u2019s disease","volume":"29","author":"Hoseinipalangi","year":"2023","journal-title":"East. Mediterr. Health J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/B978-0-323-98817-9.00012-0","article-title":"Essential tremor","volume":"196","author":"Louis","year":"2023","journal-title":"Handb. Clin. Neurol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e200162","DOI":"10.1212\/CPJ.0000000000200162","article-title":"Conversion rate of essential tremor to essential tremor Parkinson disease data from a prospective longitudinal study","volume":"13","author":"Louis","year":"2023","journal-title":"Neurol. Clin. Pract."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.parkreldis.2016.01.009","article-title":"Essential tremor is a risk factor for Parkinson\u2019s disease","volume":"24","author":"Louis","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4161\/cc.8.2.7551","article-title":"Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1","volume":"8","author":"Chen","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/mutage\/geab011","article-title":"NEK1 deficiency affects mitochondrial functions and the transcriptome of key DNA repair pathways","volume":"36","author":"Martins","year":"2021","journal-title":"Mutagenesis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1073\/pnas.1217781110","article-title":"Nek1 kinase associates with ATR-ATRIP and primes ATR for efficient DNA damage signaling","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.bbrc.2010.03.077","article-title":"Phosphorylation by Nek1 regulates opening and closing of voltage dependent anion channel 1","volume":"394","author":"Chen","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1158\/0008-5472.CAN-04-2243","article-title":"NIMA-related protein kinase 1 is involved early in the ionizing radiation-induced DNA damage response","volume":"64","author":"Polci","year":"2004","journal-title":"Cancer Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ng.3626","article-title":"NEK1 variants confer susceptibility to amyotrophic lateral sclerosis","volume":"48","author":"Kenna","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1093\/brain\/aww033","article-title":"NEK1 mutations in familial amyotrophic lateral sclerosis","volume":"139","author":"Brenner","year":"2016","journal-title":"Brain"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/S1353-8020(11)70027-X","article-title":"Parkinson\u2019s disease tremor: Pathophysiology","volume":"18","author":"Hallett","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Smith, L., and Schapira, A.H.V. (2022). GBA variants and Parkinson disease: Mechanisms and treatments. Cells, 11.","DOI":"10.3390\/cells11081261"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1007\/s12035-024-04008-8","article-title":"The molecular impact of glucosyl ceramidase Beta 1 (Gba1) in Parkinson\u2019s disease: A new genetic state of the art","volume":"61","author":"Mano","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","article-title":"Differential effects of severe vs mild GBA mutations on Parkinson disease","volume":"84","author":"Amshalom","year":"2015","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1093\/hmg\/ddaa085","article-title":"Glucocerebrosidase deficiency promotes release of \u03b1-synuclein fibrils from cultured neurons","volume":"29","author":"Gegg","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00415-021-10713-4","article-title":"Longitudinal clinical, cognitive, and neuroanatomical changes over 5 years in GBA-positive PD patients","volume":"269","author":"Leocadi","year":"2022","journal-title":"J. Neurol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.23046","article-title":"Gaucher disease ascertained through a Parkinson\u2019s center: Imaging and clinical characterization","volume":"25","author":"Hagenah","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41531-023-00571-4","article-title":"Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson\u2019s disease","volume":"9","author":"Zhou","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_42","first-page":"109","article-title":"Molecular and catalytic properties of transglutaminases","volume":"38","author":"Folk","year":"1973","journal-title":"Adv. Enzymol. Relat. Areas Mol. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1096\/fj.03-0829fje","article-title":"Tissue transglutaminase catalyzes the formation of alpha-synuclein crosslinks in Parkinson\u2019s disease","volume":"18","author":"Andringa","year":"2004","journal-title":"FASEB J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1212\/WNL.0000000000000909","article-title":"Spinocerebellar ataxia 35: Novel mutations in TGM6 with clinical and genetic characterization","volume":"83","author":"Guo","year":"2014","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.31083\/j.jin.2020.01.1203","article-title":"TGM6 variants in Parkinson\u2019s disease: Clinical findings and functional evidence","volume":"19","author":"Chen","year":"2020","journal-title":"J. Integr. Neurosci."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1184\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:01:31Z","timestamp":1760032891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,29]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071184"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071184","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,29]]}}}